Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/2/2025

Management of Heberden's Nodes in DIP Joints

Evidence for Efficacy

  • Chondroitin sulfate has shown effectiveness for relief of hand OA symptoms in one well-performed trial, making it conditionally recommended for patients with hand OA 1, 2
  • The 2019 American College of Rheumatology/Arthritis Foundation guidelines conditionally recommend chondroitin sulfate specifically for hand OA, while strongly recommending against its use for knee and hip OA 1
  • The 2019 ACR/AF guidelines strongly recommend against glucosamine for knee, hip, and hand OA based on lack of efficacy evidence 1
  • The European League Against Rheumatism (EULAR) 2018 guidelines note the absence of specific evidence supporting glucosamine for hand OA 2

Clinical Considerations

  • Both supplements generally have mild and infrequent adverse effects, and are considered safer alternatives compared to long-term NSAID use, which carries risks of gastrointestinal, cardiovascular, and renal complications 2

Treatment Algorithm for Heberden's Nodes

  • Non-pharmacological core treatments, such as exercise and weight management if applicable, are recommended as first-line approaches for Heberden's nodes 3, 4
  • Topical NSAIDs are recommended for localized pain relief as first-line approaches 3, 4
  • Oral analgesics like acetaminophen may be considered for pain control as second-line options 2
  • Chondroitin sulfate (800-1200 mg daily) may be considered for symptom relief as second-line options 2
  • Oral NSAIDs at lowest effective dose for shortest duration may be considered for inadequate response 4
  • Intra-articular corticosteroid injections may be considered for painful interphalangeal joints for inadequate response 2
  • Surgical options like arthrodesis or arthroplasty may be considered for structural abnormalities with persistent pain 2

Important Caveats

  • The National Institute for Health and Care Excellence (NICE) guidelines discourage the use of both glucosamine and chondroitin products 2, 4
  • There is no convincing evidence that either supplement has disease-modifying properties for hand OA 2
  • No drugs currently available for OA, including these supplements, have proven disease-modifying properties 2